FDA label

What is Fycompa used for?

Fycompa contains perampanel. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.

Source: DailyMed SPL label file dated 2026-10-23. Publisher page

The FDA label for Fycompa lists 2 uses: Partial-Onset Seizures; Primary Generalized Tonic-Clonic Seizures.

Run it in Rivvi

Which 2027 plans near you dropped or restricted Fycompa?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Fycompa, tablet

Indications and Usage, quoted from the label by Catalyst Pharmaceuticals, Inc. (NDA202834). Cross-references to other label sections are left out.

Partial-Onset Seizures

FYCOMPA is indicated for the treatment of partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy 4 years of age and older.

Primary Generalized Tonic-Clonic Seizures

FYCOMPA is indicated as adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in patients with epilepsy 12 years of age and older.

Source: DailyMed label, set id ec812ea3-de3a-4271-957c-db8f692d1ae3, version 4, effective January 5, 2024. NDC 69616-272, one of 12 listings for this product.

Questions

What is Fycompa used for?

The FDA label for Fycompa lists 2 uses: Partial-Onset Seizures; Primary Generalized Tonic-Clonic Seizures.

What drug class is Fycompa?

FDA lists perampanel in the Noncompetitive AMPA Glutamate Receptor Antagonist established pharmacologic class.

Does this page cover off-label uses or dosing?

No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.

More on Fycompa

Try it on your own data today.

Free to start. Most teams are using it the same day.